Cancer drug prices likely to fall as govt caps trade margins at 30%
The move could reduce the MRP of affected medicines by up to 70 per cent and result in annual savings of around Rs ₹2,500 crore for patients undergoing cancer treatment
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)